A Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus Efavirenz in Treatment Naive HIV-Infected Patients, Each in Combination With TRUVADA (0518-021 EXT)
Clinical trial NCT00369941 · COMPLETED
Trial details
- NCT number
- NCT00369941
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2009-05-01
- Enrollment
- 566
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.